Page 11 - Biomedicine

centers and 124 clinical trial hospitals. In addition, Taiwan's high-quality biotech
incubation mechanism and its interconnected network of industrial development
hubs from north to south have made Taiwan one of the world's best locations for
innovation, research, and development of new drugs and new medical devices. Future
investments by foreign companies in Taiwan in the future will help expedite the
timeline of research and development, and will introduce new products to the market
and generate business opportunities in the biophamaceutical industry for all parties.

Taiwan as the Best Manufacturing
3
and R&D Partner

Taiwan's success in curbing the COVID-19 pandemic has fully demonstrated
its responsiveness and its capabilities in R&D and manufacturing. With the technical
capabilities of the Academia Sinica and National Health Research Institutes, as well
as related biotech enterprises that are cooperating in research and development, the
nanovaccine and the glycoprotein vaccine successfully developed in Taiwan are now
being tested in clinical trials. The outstanding R&D technology of Taiwan has attracted
advanced countries such as the US and others in the European Union to work with
Taiwan in the development of vaccines. This demonstrates the unparalleled R&D and
manufacturing capabilities of Taiwan in the biopharmaceutical eld.

Production and management capabilities in Taiwan's manufacturing sector are
also the key factors that have made its medical device sector well recognized around
the world. Facial masks, protective clothing, and ventilators, for which the demand has
signicantly surged recently in the ght against the pandemic, as well as prosthetics,
contact lenses, physiological detectors, and monitoring devices are all important
contributors to growth in the medical device sector in Taiwan. With the pandemic yet
to ease, it is expected that Taiwan's ability to curb diseases is again drawing the world's
attention to our country's enhanced medical care, medical device manufacturing,
management efficiency, and fully integrated information and communication
technologies.

09